Recently Funded Biotech Companies 2026

Biotechnology and life sciences companies that closed funding rounds in the last 90 days — drug discovery, genomics, and therapeutics.

As of June 2026, these 96 companies have raised $14.9B in combined funding.

Showing top 96 of 96 matching companies · Ranked by most recent funding · Updated Jun 2026

Ollin Biosciences

Biotechnology company developing novel therapeutics.

Austin, United States11–50Biotech, Healthcare

Venture Unknown·$430.0M·Jun 2026

RQ Bio

Biotechnology company advancing precision medicine and drug development.

London, United States11–50Biotech, Healthcare

Venture Unknown·$115.0M·Jun 2026

Cadence

AI-powered remote patient monitoring platform delivering chronic disease management to patients a...

New York201–500Life Sciences

Series C·$241.0M·Jun 2026

Croivalve

Helping treat heart valve disease

Dublin, Ireland11–50Biotech, Healthcare

Extension Round·$55.4M·Jun 2026

Osanni Bio

Clinical-stage biotechnology company.

San Francisco, United States11–50Biotech, Healthcare

Venture Unknown·$230.0M·Jun 2026

Rapalogix Health

Longevity dermatology company advancing TORC1-selective skincare products and therapeutics for sk...

New York, United States1–10Biotech, Healthcare

Series A·$20.0M·Jun 2026

Serapha Bio

Gene-editing startup developing treatments for alpha-1 antitrypsin deficiency (AATD) and other ge...

San Diego, United States1–10Biotech, Healthcare

Series A·$138.0M·Jun 2026

TRIMTECH Therapeutics

Biotech developing TRIMTAC and TRIMGLUE targeted protein degradation therapies.

Cambridge, United States1–10Biotech

Seed·$45.0M·Jun 2026

Bionyra Pharma

Clinical-stage biopharma developing next-generation mono and multispecific antibodies for immune-...

Paris, France1–10Biotech

Series A·$165.0M·Jun 2026

Nura Bio

Clinical-stage biotech developing neuroprotective SARM1 inhibitor therapies for ALS and other neu...

South San Francisco, United States11–50Biotech, Healthcare

Series B·$143.8M·Jun 2026

Spot Biosystems

Biotech developing non-viral gene therapy delivery platform targeting Duchenne muscular dystrophy.

Boston, United States11–50Biotech, Healthcare

Seed·$40.0M·Jun 2026

Triveni Bio

Clinical-stage biotech using a genetics-informed approach to develop functional antibodies for im...

United States11–50Biotech, Healthcare

Venture Unknown·$272.0M·Jun 2026

Dioseve

Japanese biotech advancing IPS cell-based support for IVF treatment.

Tokyo, Japan1–10Biotech, Healthcare

Venture Unknown·$16.7M·Jun 2026

ENA Respiratory

Clinical-stage respiratory biotech developing novel treatments for respiratory diseases.

Melbourne, United Kingdom1–10Biotech, Healthcare

Series A·$162.4M·Jun 2026

Rainbow Crops

AI-powered gene editing for improved crop varieties.

Ghent, Belgium1–10AgriTech, Biotech

Seed·$21.5M·Jun 2026

Hyperion

Life sciences company.

United StatesLife Sciences

Seed·$11.5M·Jun 2026

LTZ Therapeutics

Biotech therapeutics development company focused on pharmaceutical innovation.

Shenzhen, China11–50Biotech, Healthcare

Venture Unknown·$106.0M·Jun 2026

NIRRIN TECHNOLOGIES INC

R&D company with 1 SBIR/STTR awards from Department of Health and Human Services.

Billerica, United States1–10Biotech, Healthcare

Funding undisclosed

Radical Numerics

AI research lab building general biological intelligence models trained on DNA, RNA, and protein ...

San Francisco, United States11–50Artificial Intelligence, Biotech

Seed·$50.0M·Jun 2026

Ethyreal Bio

Biotech developing ETHY-001, a best-in-class anti-TSHR antibody targeting root causes of Graves' ...

San Francisco, United States1–10Biotech, Healthcare

Seed·$101.0M·Jun 2026

SonoThera

Ultrasound-mediated non-viral gene therapy platform for non-invasive, targeted genetic medicine d...

United StatesBiotech, Healthcare

Series B·$185.8M·Jun 2026

NewLeaf Symbiotics

Biological technology provider and global leader in PPFM microbials for modern production agricul...

United States11–50Agtech, Biotech

Series A·$161.0M·Jun 2026

Sampled

Next-generation laboratory providing storage, management, analysis, and transportation for biolog...

United States51–200Biotech, Healthcare

Pre-seed·$500K·Jun 2026

City Therapeutics

Clinical-stage biotech developing next-generation RNAi therapeutics for thromboembolic and other ...

Cambridge, United StatesBiotech, Healthcare

Series B·$234.5M·Jun 2026

Waypoint Bio

Biotechnology company pioneering AI-powered cell therapies for solid tumors.

New York, United States11–50Artificial Intelligence, Biotech

Series A·$34.5M·Jun 2026

More Rankings

Most Funded Companies Recently Funded Startups Top VC-Backed Startups Recently Funded AI Top Pre-Seed Startups Top Seed Startups Top Series A Companies Top Series B Companies View all lists →